Ivan Horak

Ivan Horak

Geen lopende functies
75 jaar
Health Technology
Commercial Services
Consumer Services

Profiel

Dr. Ivan D.
Horak
, MD, is a Chief Executive Officer & Director at Tikva Allocell Pte Ltd., a Member at American Association for Cancer Research, a Member at American Society of Clinical Oncology, Inc., a Member at American Society of Hematology and a Venture Advisor at Israel Biotech Fund.
He is on the Board of Directors at Tikva Allocell Pte Ltd. Dr. Horak was previously employed as a Chief Medical & Scientific Officer by Tessa Therapeutics Ltd, a Chief Scientific Officer by Enzon Pharmaceuticals, Inc., a Chief Scientific Officer & Executive VP by Immunomedics, Inc., a Vice President-Clinical Oncology by Pharmacia Corp., a Director-Oncology Clinical Research & Development by The Janssen Research Foundation, a Principal by American College of Physicians, Inc. /Old/, and a Member by Union for International Cancer Control.
He received his doctorate degree from the University of Commenius.

Actieve functies van Ivan Horak

BedrijvenFunctieBegin
Corporate Officer/Principal -
Corporate Officer/Principal -
Corporate Officer/Principal -
Consultant / Adviseur -

Eerdere bekende functies van Ivan Horak

BedrijvenFunctieEinde
Hoofd Techniek/Wetenschap/O&O 04-04-2011
IMMUNOMEDICS, INC. Hoofd Techniek/Wetenschap/O&O 02-09-2005
Corporate Officer/Principal 01-05-2002
The Janssen Research Foundation
Hoofd Techniek/Wetenschap/O&O 01-01-1999
President -
Ervaring van Ivan Horak in detail bekijken

Opleiding van Ivan Horak

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Connecties

79

Eerstegraads connecties

12

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Verwante bedrijven

Bedrijven in privébezit12

Health Technology

Health Technology

Union for International Cancer Control

Health Technology

Consumer Services

Health Services

Commercial Services

Commercial Services

Commercial Services

The Janssen Research Foundation

Health Technology

Finance

  1. Beurs
  2. Insiders
  3. Ivan Horak
40 % korting: de beste tools voorbehouden aan abonnees om de beste beleggingen van morgen te identificeren!
d
:
:
PROFITEER NU